ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B
Phase 4
Active, not recruiting
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Stop group
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 140
- Registration Number
- NCT04782375
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Chung-Ang University Hospital, Seoul, Korea, Republic of
Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels
Phase 4
Active, not recruiting
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Treatment
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 600
- Registration Number
- NCT04780204
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Chung-Ang University Hospital, Seoul, Korea, Republic of
Prospective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique View
Not Applicable
Completed
- Conditions
- Cervical Radicular PainCervical Spinal StenosisCervical Intervertebral Disc DiseaseHerpes ZosterPostherpetic Neuralgia
- Interventions
- Procedure: Fluoroscopic-guided cervical epidural access
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 439
- Registration Number
- NCT04774458
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Development of Molecular Diagnostic Platform for Tuberculosis
Not Applicable
- Conditions
- Tuberculosis
- Interventions
- Diagnostic Test: New technique vs Xpert
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT04734236
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Songpa, Korea, Republic of
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 201
- Registration Number
- NCT04714697
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Fluvoxamine for Adults With Mild to Moderate COVID-19
Phase 2
Suspended
- Conditions
- Severe Acute Respiratory Syndrome Coronavirus 2Mild to Moderate COVID-19Coronavirus Infection
- Interventions
- Drug: PlaceboDrug: Fluvoxamine
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT04711863
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 95
- Registration Number
- NCT04696042
- Locations
- 🇰🇷
Changhoon Yoo, Seoul, Korea, Republic of
Effect of Neck Extension on Intraocular Pressure in Patients Undergoing Palatoplasty
Completed
- Conditions
- Cleft Palate
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT04683978
- Locations
- 🇰🇷
Asan medical Center, Seoul, Korea, Republic of
Comparison of PENG Block and FICB in Hip Fracture Patients
Not Applicable
Completed
- Conditions
- Hip FracturesRegional Anesthesia
- Interventions
- Procedure: Fascia iliaca compartment block (FICB)Procedure: Pericapsular nerve group (PENG) block
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04677348
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma
Phase 1
Active, not recruiting
- Conditions
- Pancreatic CancerPancreatic Ductal Adenocarcinoma
- Interventions
- Drug: NASOX
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04662112
- Locations
- 🇰🇷
Hallym University Medical Center, Anyang, Gyeonggi, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath